Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice.
Zhang, G; Kang, Y; Cathey, D; LeBlanc, AJ; Cai, J; Cai, L; Wang, S; Huang, J; Keller, BB.
Cardiovascular Drugs and Therapy.
2022;
36:425-436.
Isolated Coarctation of the Aorta: Current Concepts and Perspectives.
Bhatt, AB; Lantin-Hermoso, MR; Daniels, CJ; Jaquiss, R; Landis, BJ; Marino, BS; Rathod, RH; Vincent, RN; Keller, BB; Villafane, J.
Frontiers in Cardiovascular Medicine.
2022;
9.
Pulmonary hypertensive crisis in children with pulmonary arterial hypertension undergoing cardiac catheterization.
Li, Q; Zhang, C; Wang, R; Keller, BB; Gu, H.
Pulmonary Circulation.
2022;
12.
Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways.
Wang, X; Chen, X; Zhou, W; Men, H; Bao, T; Sun, Y; Wang, Q; Tan, Y; Keller, BB; Tong, Q; et al.
Acta Pharmaceutica Sinica B.
2022;
12:708-722.
Emerging roles of microRNA-208a in cardiology and reverse cardio-oncology.
Wang, X; Chen, X; Xu, H; Zhou, S; Zheng, Y; Keller, BB; Cai, L.
Medicinal Research Reviews.
2021;
41:2172-2194.
Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension.
Xu, Z; Gatzoulis, MA; Dimopoulos, K; Li, Q; Zhang, C; Keller, BB; Gu, H.
CJC open.
2021;
3:872-879.
Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy.
Wang, X; Chen, XX; Yu, HT; Tan, Y; Lin, Q; Keller, BB; Zheng, Y; Cai, L.
Acta Pharmacologica Sinica.
2021;
42:932-941.
Zinc as a countermeasure for cadmium toxicity.
Yu, H; Zhen, J; Leng, J; Cai, L; Ji, H; Keller, BB.
Acta Pharmacologica Sinica.
2021;
42:340-346.
Successful outcomes for atrial septal defect associated with pulmonary arterial hypertension using a “treat-repair-treat” strategy.
He, Y; Li, Q; Zhang, C; Keller, BB; Gu, H.
International journal of cardiology congenital heart disease.
2021;
2.
Chronic Optogenetic Pacing of Human-Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissues.
Dwenger, M; Kowalski, WJ; Masumoto, H; Nakane, T; Keller, BB.
Methods in Molecular Biology.
2021;
2191:151-169.